-
An educational resource from the BJC
Working with expert academics, professional bodies and clinicians in the field, BJC Learning offers rigorous and comprehensive modular e-learning programmes. It’s free to use and modules can be completed at your own pace. Self-assessment with online certification enables you to gain credits for continuing medical education activities at any time.
View our latest modules:
Heart failureBJC Learning has revised our comprehensive modular e-learning programme with the latest studies and guidance covering all aspects of this growing problem.
ACS management
In this learning programme, based on a BJC supplement ‘The post-acute coronary syndrome patient: optimising management’, we learn how to optimise management of the post-acute coronary syndrome (ACS) patient.
Amyloid heart disease
These standalone modules will cover the diagnosis and management of amyloid heart disease – including clinical indicators of transthyretin amyloidosis that should prompt further investigation, the diagnostic tests and how they combine in a diagnostic framework, as well as a comprehensive approach to supportive care in order to preserve organ function and treatments to reduce transthretin (TTR) in the plasma, and stabilise the tetramic structure of TTR.
Angiography
The ability to perform invasive diagnostic coronary angiography is a core requirement for cardiologists and fellows in training programmes. However, although key to their independence is the ability to obtain high-quality images that allow visualisation of the entire coronary vasculature, there exists no formal systematic method or teaching aid. This article provides an overview of the radiological equipment used in the catheter laboratory, details the naming of the different angiographic projections, and gives key tips and tricks to improve image quality. In addition, the coronary vasculature is broken down into segments, with descriptions provided of the essential views required to image each one. Using this approach, it aims to provide an essential aid to trainees and other healthcare professionals at the start of their careers.
Anticoagulation
Many common problems in clinical practice relate to arterial and venous thrombosis. Our programme will help give you a clear understanding of anticoagulation from the underlying pathways to the new medical treatments and best clinical management.
Diabetes and CVD
CVD is a common cause of morbidity and mortality in people with diabetes. It is also recognised that patients with established CVD have a high prevalence of undiagnosed diabetes, and up to one third will have prediabetic states. Atherosclerotic events are reducing in people with diabetes as a consequence of the widespread use of statins and antihypertensive medications, and heart failure is now the most common first presenting cardiovascular condition in people with type 2 diabetes.
Digoxin: current clinical uses and management of toxicity
Digoxin is a medication commonly used in the treatment of heart failure and/or atrial fibrillation. This learning module is designed to give healthcare professionals (HCPs) involved in the management of patients with atrial fibrillation and/or congestive heart failure (cardiologists, geriatricians and other HCPs that manage the care of older persons, clinical pharmacists and GPs) an introduction to the current clinical use of digoxin. The module also reviews the pharmacology and mechanism of action of this cardiac glycoside. Overdose of digoxin may provoke troublesome arrhythmias or malignant hyperkalaemia. The module highlights the mechanism of digoxin toxicity, the important diagnostic aspects and outlines the various approaches to treatment depending on its acute or chronic nature.
Heart failure
Heart failure prevalence is high, and rising due to the increasing age of the population. To help you get up-to-date in this increasingly important area, BJC Learning in partnership with the British Society for Heart Failure, has published a comprehensive programme covering all aspects of this growing problem.
Heart valve disease
New technologies are revolutionising life for patients with heart valve disease. Our programme, written in partnership with the British Heart Valve Society, covers all aspects of this growing problem, now the third most common cardiac disease.
Hyperkalaemia
Hyperkalaemia is an often asymptomatic condition, caused by elevated levels of serum potassium, and can cause a number of different heart problems, such as arrhythmia. Our new standalone article will provide a clinical update on novel potassium binders, including how to enable patients to stay on optimal renin–angiotensin–aldosterone system (RAAS) inhibition, and the efficacy and safety of two novel potassium binders for the treatment of hyperkalaemia.
We also have a podcast which will provide an understanding of the causes of hyperkalaemia and how we can manage it, the role of diet and new drugs.
Pulmonary hypertension
Pulmonary hypertension is now a treatable condition. But while treatments improve some forms of the disease, they can worsen others. So achieving an accurate diagnosis is essential. Our programme will guide you on the management of these patients.
